Review of the safety and efficacy of imiglucerase treatment of Gaucher disease
Deborah Elstein, Ari ZimranGaucher Clinic, Shaare Zedek Medical Center, Jerusalem, IsraelAbstract: Most patients who suffer from symptomatic Gaucher disease will benefit from enzyme replacement therapy (ERT) with imiglucerase. The safety profile is excellent, only a small percentage of those exposed...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-08-01
|
| Series: | Biologics: Targets & Therapy |
| Online Access: | http://www.dovepress.com/review-of-the-safety-and-efficacy-of-imiglucerase-treatment-of-gaucher-a3497 |